Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 25 to 32 6/7 weeks gestation~* Singleton or twin gestation~* Received 1st course of betamethasone prior to 30 weeks' gestation~* Began 1st course of betamethasone at least 14 days prior to randomization~* Risk of delivery in next 7 days due to either maternal or fetal complication (e.g. preterm labor, severe preeclampsia, IUGR, etc.)~* Intact membranes~Exclusion Criteria:~* Known major fetal anomalies (eg: anencephaly, renal agenesis etc...)~* High order multiple gestation (triplets or higher)~* Cervical dilation \> 5 cm~* Clinical chorioamnionitis prior to initiation of second course (two or more of the following; antepartum temperature \> 38ºC (100.4ºF), uterine tenderness, foul smelling vaginal discharge or amniotic fluid, maternal tachycardia (\>100beats/min), fetal tachycardia (\>160 beats/min), or white blood cell count \>20x109/L.define)~* Ruptured membranes prior to initiation of second course of betamethasone~* Already receiving corticosteroids for other conditions (e.g. Lupus, asthma)~* Maternal condition contraindicating the use of steroids (e.g. HIV, active Tuberculosis)~* Participation in conflicting study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 Test group (Type: ACTIVE_COMPARATOR): Receive 2nd Course = Study drug (betamethasone or dexamethasone)
- 2 - Control (Type: PLACEBO_COMPARATOR): Placebo group = received placebo course

Based on this trial design, predict the completion outcome and termination type (if applicable).